Abstract
Studies on the clinical use of evoked potentials (EP) in psychiatry date back to the mid-1960s, when Callaway et al. (1965) and Rodin et al. (1964) described EP alterations in schizophrenia. The first book about the use of EP in psychiatry appeared in 1972 (Shagass 1972). The most consistent finding in the following studies by Roth etal. (1981) and Pfefferbaum et al. 1984 b) was a reduction of P300 amplitudes in schizophrenia and dementia. For schizophrenia, this reduction seemed to be the most robust and replicable waveform alteration indicating biological deficits in this disease. Despite all these valuable results, the EP method did not gain the degree of clinical significance that would have been necessary for routine use of EP for differential diagnosis and drug monitoring. One reason might be the nonspecificity of EP alterations, which are often similar in different diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer’s desease. Arch Psychiatry Neurol 223:15–33
Bruni A, Toffano G (1982) The principles of phospholipid pharmacology. In: Antolini E et al. (eds) Transport in biomembrana: model systems and reconstruction. Raven, New York, pp 235–242
Callaway E, Jones RT, Lyne RS (1965) Evoked responses and segmental set of schizophrenia. Arch Gen Psychiatry 12:83–89
Duffy HF, Buchfleld JL, Lombroso CT (1979) Brain electrical activity mapping (BEAM): a method for extending the clinical utility of EEG and evoked potentials data. Ann Neurol 5:309–321
Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Chiro G (1984) Cortical abnormalities in Alzheimer’s disease. Ann Neurol 16:649–654
Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alteration in dementia of the Alzheimer type: positron emission tomography with Fluorodeoxyglucose. J Comput Assist Tomogr 7:590–598
Halgren E, Squires NK, Wilson CL, Crandall PH (1982) Brain generators of evoked potential: the late (endogenous) components. Bull Los Angeles Neurol Soc 47:108–123
Hegerl K, Klotz S, Ullrich G (1985) Spate akustisch evozierte Potentiale - Einfluß von Alter, Geschlecht und verschiedenen Untersuchungsbedingungen. Z EEG-EMG 16:171
Lowitzsch K, Maurer K, Hopf HC (1983) Evozierte Potentiale in der klinischen Diagnostik. Thieme, Stuttgart
Maurer K, Leitner H, Schafer E (1982) Akustisch evozierte Potentiale. Enke, Stuttgart
Maurer K, Lowitsch K, Stöhr M (1987) Evozierte Potentiale, Einführung und Atlas. Enke, Stuttgart
McCarley RW, Torello M, Shenton M, Duffy FH (1985) The topography of P300 and spectral energy in schizophrenics and normals. In: Chagass RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry. Elsevier, Amsterdam, 389–391
Morihisa JM, Duffy FH, Wyatt RJ (1983) Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiatry 40:719–726
Morstyn R, Duffy FH, McCarley RW (1983) Altered P300 topography in schizophrenia. Arch Gen Psychiatry 40:729–734
Okada YC, Kaufman L, Williamson SJ (1983) The hippocampal formation as a source of the slow endogenous potentials. Electroencephalogr Clin Neurophysiol 55:417–426
Pfefferbaum A, Ford JM, Wenegrat BG, Roth WT, Kopell BS (1984a) Clinical application of the P3 component of event-related potentials in normal aging. Electroencephalogr Clin Neurophysiol 59:85–103
Pfefferbaum A, Wenegrat BG, Ford JM, Roth WT, Kopell BS (1984b) Clinical application of the P3 component of event-related potentials: II. Dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol 59:104–124
Reisberg B, London E, Ferris SH, Borenstein J, Scheier L, de Leon MJ (1983) The brief cognitive rating scale: language motoric and mood, concomitants in primary degenerative dementia (PDD). Psychopharmacol Bull 19:702–708
Reynolds GP (1983) Increased concentration and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305:527–528
Rodin E, Zacharopoulos G, Beckett P, Frohman C (1964) Characteristics of visually evoked responses in normal subjects and schizophrenic patients. Electroencephalogr Clin Neurophysiol 17:451
Roth WT, Pfefferbaum A, Kelly AF, Berger PA, Kopell BS (1981) Auditory event-related potentials in schizophrenia and depression. Psychiatry Res 4:199–212
Shagass C (1972) Evoked potentials in psychiatry. Plenum, New York
Spohn HE, Lacoursiere RB, Tompson K (1977) Phenothioazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Arch Gen Psychiatry 34:633–644
Stigsby B, Johanneson G, Ingvar D (1981) Regional EEG analysis and regional cerebral blood flow in Alzheimer’s and Pick’s disease. Electroencephalogr Clin Neurophysiol 51:537–547
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Maurer, K., Dierks, T., Ihl, R., Laux, G. (1989). Mapping of Evoked Potentials in Normals and Patients with Psychiatric Diseases. In: Maurer, K. (eds) Topographic Brain Mapping of EEG and Evoked Potentials. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72658-3_51
Download citation
DOI: https://doi.org/10.1007/978-3-642-72658-3_51
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72660-6
Online ISBN: 978-3-642-72658-3
eBook Packages: Springer Book Archive